22.02.2013 Views

SMASAC Working Group Post Polio Syndrome - Scottish Health On ...

SMASAC Working Group Post Polio Syndrome - Scottish Health On ...

SMASAC Working Group Post Polio Syndrome - Scottish Health On ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Scottish</strong> Medicines and Scientific Advisory Committee <strong>Working</strong> <strong>Group</strong><br />

<strong>Post</strong> <strong>Polio</strong> <strong>Syndrome</strong>/Late Effects of <strong>Polio</strong><br />

The development of new symptoms in an individual considered to have had<br />

polio may be due to PPS, LEOP, or the development of an unrelated health<br />

problem. It is the remit of primary care to interpret symptoms and refer on to<br />

the appropriate professional. New weakness should ideally generate a referral<br />

to neurological services whose skills and resources are essential to make a<br />

diagnosis of the cause of new weakness.<br />

Presence of any of the following in an individual considered to have had polio<br />

should prompt consideration of PPS/LEOP:<br />

• Falls.<br />

• New pain in an area not previously affected.<br />

• New or evolving wasting.<br />

• Sensory symptoms such as tingling or numbness especially in a<br />

discrete area (for LEOP only).<br />

• New dysphagia.<br />

• The development of more than one respiratory infection in 12<br />

months requiring antibiotics.<br />

• Any fracture.<br />

As noted in Section 2.10, individuals with PPS/LEOP who develop respiratory<br />

symptoms must have appropriate assessment, including exclusion of other<br />

causes. Those who have polio related respiratory problems and a significantly<br />

reduced vital capacity will require access to sleep studies and may need non<br />

invasive ventilatory support.<br />

5.3 Determining the prevalence of PPS/LEOP in Scotland<br />

As described earlier in this report, there would be considerable difficulty in<br />

establishing a more accurate estimate of prevalence than that which is<br />

currently available based on existing literature. The group therefore<br />

recommends, for planning purposes, that the prevalence of PPS/LEOP in<br />

Scotland is accepted as between 1,000 and 6,000 individuals.<br />

35

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!